Basilea Pharmaceutica AG
SIX:BSLN

Watchlist Manager
Basilea Pharmaceutica AG Logo
Basilea Pharmaceutica AG
SIX:BSLN
Watchlist
Price: 43.65 CHF -1.47% Market Closed
Updated: May 20, 2024

Basilea Pharmaceutica AG
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Basilea Pharmaceutica AG
Selling, General & Administrative Peer Comparison

Comparables:
ADCT
ACIU
CRSP
IDIA
KURN

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
Basilea Pharmaceutica AG
SIX:BSLN
Selling, General & Administrative
-CHf33.8m
CAGR 3-Years
-5%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
ADC Therapeutics SA
NYSE:ADCT
Selling, General & Administrative
-$105.9m
CAGR 3-Years
-4%
CAGR 5-Years
-65%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Selling, General & Administrative
-CHf10.6m
CAGR 3-Years
2%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Selling, General & Administrative
-$206.8m
CAGR 3-Years
-30%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Selling, General & Administrative
-CHf504m
CAGR 3-Years
-100%
CAGR 5-Years
-75%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Selling, General & Administrative
-CHf27.5m
CAGR 3-Years
-44%
CAGR 5-Years
-25%
CAGR 10-Years
N/A

See Also

What is Basilea Pharmaceutica AG's Selling, General & Administrative?
Selling, General & Administrative
-33.8m CHF

Based on the financial report for Dec 31, 2023, Basilea Pharmaceutica AG's Selling, General & Administrative amounts to -33.8m CHF.

What is Basilea Pharmaceutica AG's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-5%

Over the last year, the Selling, General & Administrative growth was -10%. The average annual Selling, General & Administrative growth rates for Basilea Pharmaceutica AG have been -5% over the past three years , -1% over the past five years , and -5% over the past ten years .